MichaelPatrickFlahertyMDPhD

Summary

• Dr. Flaherty specializes in the following: Percutaneous coronary interventions: including high risk procedures requiring percutaneous mechanical support, Percutaneous peripheral arterial interventions.
  Treatment of adult congenital heart disease: patent foramen ovale, atrial septal defects, pulmonic valvular stenosis, and patent ductusarteriosus, Mitraclip mitral valve repair, precutaneous treatment of valvular stenosis: including aortic and mitral and pulmonic stenosis. Alcohol-induced myocardial septal ablation, Adult stem cell therapy for myocardial regeneration.
  Clinical Research Interests:Percutaneous hemodynamic support for high-risk PCI Percutaneous hemodynamic support in cardiogenic shock complicated by acute MI Percutaneous aortic valve replacement ~

Regional Heart Specialists
Launching Soon

Impella® Heart Pump and Reduced Occurrence of Acute Kidney Injury in High-Risk P
Dr. Michael Flaherty discusses the retrospective, single-center study published in Circulation Research which finds that use of hemodynamic support with Impella

KentuckyOne performs new heart valve treatment - Louisville - Louisville Busines
Louisville-based KentuckyOne Health Inc. says its Jewish Hospital heart valve team is the first in Louisville to complete a new heart procedure for those too il

Dr. Flaherty on TAVR being the next gold standard for aortic stenosis
Why Choose Jewish Hospital for your TAVR?
New Study Finds Abiomed Impella® Heart Pump Reduces Injury to Kidneys During Hig
DANVERS, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- A new study published in Circulation Research finds use of hemodynamic support with Impella® 2.5 heart pump d